Present status of purine analogs in the therapy of chronic lymphocytic leukemias

Leukemia

Volumn 11, Issue SUPPL. 2, 1997, Pages

  Bergmann, L ^a,b  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

2 chlorodeoxyadenosine; 2 deoxycoformycin; Chronic lymphocyte leukemia; Fludarabine

Indexed keywords

CHLORAMBUCIL; CLADRIBINE; CYTARABINE; DOXORUBICIN; FLUDARABINE; PENTOSTATIN; PREDNISONE; PURINE DERIVATIVE;

BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; CONFERENCE PAPER; CYTOPENIA; DRUG EFFICACY; HUMAN; IMMUNE DEFICIENCY; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA REMISSION; MENTAL DISEASE; NAUSEA; PNEUMONIA; PRIORITY JOURNAL; RASH; SEPTICEMIA; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; THROMBOCYTOPENIA;

EID: 0030915892     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Lennert K, Mohri N. Histopathology and diagnosis of non-Hodgkin's lymphomas. In: Lennert K (ed). Malignant Lymphomas. Springer Verlag: Berlin, 1978, pp 106-152.
2. Montserrat E, Rozman C. Chronic lymphocytic leukemia: present status. Ann Oncol 1995; 6: 219-235.
3. Knospe WH, Loeb V, Huguley CM. Bi-weekly chlorambucil treatmem of chronic lymphocytic leukemia. Cancer 1974; 31: 502-508.
4. Rai KR, Peterson 3, Kolitz J, Elias L, Shepherd L, Mines J, Cheson B, Schiffer C. Fludarabine induces a high complete remission rate in previously untreated patients with active lymphocyiic leukemia (CLL). A randomized inter-group study. Blood 1995; 86 (Suppl. 1): 607a.